Clinical Trial Update: Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating lenalidomide in combination with cetuximab for metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Revlimid (lenalidomide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Colon Cancer, Rectal Cancer | Phase 1 | Status: TERMINATED